Farley Chele Chiavacci
SEC insider (Form 3/4/5 filer). CIK 0001908750. Director at CDT Equity Inc. (CDT) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Feb 19, 2026. Located in NAPLES, FL.
Companies Farley Chele Chiavacci has filed insider reports for
- CDT Equity Inc. (CDT): Director
- General Purpose Acquisition Corp. (GPAC): Director
Farley Chele Chiavacci
CIK: 0001908750
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Feb 19, 2026CDT
CDT Equity Inc.
AwardDirect10.6K shares at avg. $1.04$11K - Aug 12, 2025CDT
CDT Equity Inc.
AwardDirect35K shares- - Aug 5, 2025CDT
CDT Equity Inc.
AwardDirectStock Option (Right to Buy)
15K shares- - Mar 30, 2025CDT
CONDUIT PHARMACEUTICALS INC.
AwardDirect32K shares at avg. $0.89$28K - Dec 18, 2024CDT
CONDUIT PHARMACEUTICALS INC.
AwardDirectStock Option (Right to Buy)
420K shares at avg. $0.07- - Nov 18, 2024CDT
CONDUIT PHARMACEUTICALS INC.
AwardDirect299.2K shares at avg. $0.09$27K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 19, 2026 |  CDT CDT Equity Inc. | Award | 10,553 | $1.04 | $10,975 | Direct |
| Aug 12, 2025 | CDT CDT Equity Inc. | Award | 35,000 | - | - | Direct |
| Aug 5, 2025 | CDT CDT Equity Inc. | Award Stock Option (Right to Buy) | 15,000 | - | - | Direct |
| Mar 30, 2025 | CDT CONDUIT PHARMACEUTICALS INC. | Award | 32,022 | $0.89 | $28,500 | Direct |
| Dec 18, 2024 | CDT CONDUIT PHARMACEUTICALS INC. | Award Stock Option (Right to Buy) | 420,000 | $0.07 | - | Direct |
| Nov 18, 2024 | CDT CONDUIT PHARMACEUTICALS INC. | Award | 299,238 | $0.09 | $27,500 | Direct |
1-6 of 6 transactions